Cellon
Single-use bioprocessing products for sterile liquid management.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
N/A | Series D | ||
| Total Funding | 000k | ||
Established in 1987, Cellon is a manufacturer specializing in single-use products designed for the bioprocessing, storage, and transport of sterile solutions. The company serves pharmaceutical and biotech companies involved in the production of biological drugs, vaccines, and cell and gene therapies.
Cellon’s product portfolio includes sterile bottles, custom tube and bottle sets, and platinum-cured silicone tubing. A key product line is PharmaTainer, which consists of low-particulate, single-use bottles and carboys for storing and transporting bulk vaccines, biopharmaceuticals, and culture media. These containers are produced in an ISO Class 5 environment, sterilized by radiation, and feature unique serial numbers for traceability. The company operates a 54,000 sq. ft. manufacturing facility in Luxembourg.
In a strategic move to create a dedicated single-use bioprocessing platform, 3i Group plc acquired Cellon, alongside Silicone Altimex and TBL Performance Plastics. This merger established a new entity with a comprehensive suite of single-use technology (SUT) solutions and cleanroom production capabilities in both North America and Europe. The founder-owners of Cellon and TBL have remained in key leadership roles within the new platform to ensure continuity and drive growth.
Keywords: single-use bioprocessing, sterile liquid storage, biopharmaceutical manufacturing, vaccine production, cell therapy solutions, gene therapy supplies, sterile transport containers, PharmaTainer, custom bioprocessing assemblies, silicone tubing, sterile bottles, biotech materials